Loading…
Reported covered position: Asst. to the Speaker of the House for Policy
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2014 · second_quarter · 2T
Patient Protection and Affordable Care Act (PPACA) implementation issues; Coverage and pricing policies for molecular diagnostic cancer tests; Implementation of the Protecting Access to Medicare Act of 2014; 21st Century Cures Initiative.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Medicare reimbursement and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2014 Medicare Budget proposals; Implementation of the Protecting Access to Medicare Act of 2014; 21st Century Cures Initiative.
Source: Senate LDA
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Physician Pathology Services Continuity Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Temporary Payroll Tax Cut Continuation Act of 2011
Client: CARIS SCIENCE INC · Firm: CARIS SCIENCE, INC.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Budget Control Act of 2011; Sustainable Growth Rate reform; Medicare reimbursement and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2014 Medicare Budget proposals; Implementation of the Protecting Access to Medicare Act of 2014; 21st Century Cures Initiative.
Sustainable Growth Rate reform; Clinical lab and physician fee schedule reforms and beneficiary cost sharing proposals; President Obama's FY2014 Medicare Budget proposals; Implementation of the Protecting Access to Medicare Act of 2014; 21st Century Cures Initiative.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2014 · first_quarter · Q1
Patient Protection and Affordable Care Act (PPACA) implementation issues; Coverage and pricing policies for molecular diagnostic cancer tests.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2015 Medicare funding proposals.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Budget Control Act of 2011; Sustainable Growth Rate reform; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2015 Medicare funding proposals; advanced molecular diagnostic policy; lab and pathology coverage and payment issues.
Sustainable Growth Rate reform; Clinical lab and physician fee schedule reforms and beneficiary cost sharing proposals; President Obama's FY2015 Medicare funding proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2013 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (PPACA) implementation issues; Coverage and pricing policies for molecular diagnostic cancer tests.
Sustainable Growth Rate reform; Clinical lab and physician fee schedule reforms and beneficiary cost sharing proposals; President Obama's FY2014 Medicare funding proposals.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Sustainable Growth Rate reform; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2014 Medicare funding proposals.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2014 Medicare funding proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2013 · third_quarter · Q3
Patient Protection and Affordable Care Act (PPACA) implementation issues; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2014 Medicare funding proposals.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Coverage and pricing policies for molecular diagnostic cancer tests.
Sustainable Growth Rate reform; Clinical lab and physician fee schedule reforms and beneficiary cost sharing proposals; President Obama's FY2014 Medicare funding proposals.
Patient Protection and Affordable Care Act (PPACA) implementation issues; Budget Control Act of 2011; Sustainable Growth Rate reform; Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule; President Obama's FY2014 Medicare funding proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2013 · second_quarter · Q2
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011, and Medicare Clinical Laboratory Fee Schedule reimbursement issues including pricing for and coverage of molecular diagnostic tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2013 · first_quarter · Q1
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · fourth_quarter · Q4
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · third_quarter · Q3
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · second_quarter · 2A
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · second_quarter · 2A
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · first_quarter · 1A
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · second_quarter · Q2
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2012 · first_quarter · Q1
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · first_quarter · RA
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · fourth_quarter · Q4
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · third_quarter · Q3
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organization, Sustainable Growth Rate reform, pathology reimbursement issues.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · second_quarter · Q2
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organization, Sustainable Growth Rate reform, pathology reimbursement issues.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · first_quarter · 1A
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organization, Sustainable Growth Rate reform, pathology reimbursement issues.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · second_quarter · Q2
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · first_quarter · Q1
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
CARIS SCIENCE INC via CARIS SCIENCE, INC.
2011 · first_quarter · RR
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P).Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, Fee schedule placement of genomic and genetic tests, Proposed CY2012 Medicare Physician Fee Schedule Rule (CMS-1590-P). Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Budget Control Act of 2011, Sustainable Growth Rate reform, S 3187 the FDA Safety and Innovation Act. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Patient Protection and Affordable Care Act (PPACA) implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, Sustainable Growth Rate reform. Medicare funding and beneficiary cost-sharing for Clinical Lab Fee Schedule in HR 3630-The Middle Class Tax Relief & Job Creation Act of 2012 and HR 3765-The Temporary Payroll Tax Cut Continuation Act of 2011.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Reimbursement and cost sharing issues for lab-developed tests, PPACA implementation issues, HR 2461- The Physician Pathology Continuity Act, HR 3207-Modernizing Lab Test Standards for Patients Act of 2011, Integrity in Medicare Self Referral for Lab & Pathology issues, Budget Control Act of 2011, HR 3765-Temporary Payroll Tax Cut Continuation Act of 2011, Sustainable Growth Rate reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organization, Sustainable Growth Rate reform, pathology reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organization, Sustainable Growth Rate reform, pathology reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform